Y-mabs therapeutics to present at 41st annual j.p. morgan healthcare conference

New york, jan. 03, 2023 (globe newswire) -- y-mabs therapeutics, inc. (the “company” or “y-mabs”) (nasdaq: ymab) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that its founder, president and interim chief executive officer, thomas gad, will provide an overview and update on the company's business at the virtual 41st annual j.p. morgan healthcare conference. the presentation will take place on wednesday, january 11, 2023, at 5:15 pm eastern standard time. the presentation can be accessed via a live audio webcast.
YMAB Ratings Summary
YMAB Quant Ranking